Thrombotic microangiopathy

Roberto Pisoni, Giuseppe Remuzzi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while the term 'thrombotic thrombocytopenic purpura' (TTP) refers to adult cases of TMA with predominant neurological abnormalities. HUS and TTP show the same histological lesion characterized by widening of the subendothelial space and microvascular thrombosis and their different manifestations are secondary to the different distribution of the microvascular lesions. Available evidence orients towards endothelial injury as an important factor in the sequence of events leading to the microangiopathic process. Here we provide an overview of the pathophysiology, epidemiology, clinical manifestations, and management of TMA. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)135-139
Number of pages5
JournalEuropean Journal of Internal Medicine
Volume11
Issue number3
DOIs
Publication statusPublished - Jun 2000

Fingerprint

Thrombotic Microangiopathies
Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
Hemolytic Anemia
Microcirculation
Platelet Aggregation
Thrombocytopenia
Epidemiology
Thrombosis
Kidney
Wounds and Injuries

Keywords

  • Hemolytic uremic syndrome
  • Microangiopathic hemolytic anemia
  • Microcirculation
  • Platelet thrombi
  • Thrombocytopenia
  • Thrombotic microangiopathy
  • Thrombotic thrombocytopenic purpura

ASJC Scopus subject areas

  • Medicine(all)
  • Internal Medicine

Cite this

Thrombotic microangiopathy. / Pisoni, Roberto; Remuzzi, Giuseppe.

In: European Journal of Internal Medicine, Vol. 11, No. 3, 06.2000, p. 135-139.

Research output: Contribution to journalArticle

Pisoni, Roberto ; Remuzzi, Giuseppe. / Thrombotic microangiopathy. In: European Journal of Internal Medicine. 2000 ; Vol. 11, No. 3. pp. 135-139.
@article{0f96bd7f4f2a482fbe6d652bc3736957,
title = "Thrombotic microangiopathy",
abstract = "The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while the term 'thrombotic thrombocytopenic purpura' (TTP) refers to adult cases of TMA with predominant neurological abnormalities. HUS and TTP show the same histological lesion characterized by widening of the subendothelial space and microvascular thrombosis and their different manifestations are secondary to the different distribution of the microvascular lesions. Available evidence orients towards endothelial injury as an important factor in the sequence of events leading to the microangiopathic process. Here we provide an overview of the pathophysiology, epidemiology, clinical manifestations, and management of TMA. (C) 2000 Elsevier Science B.V.",
keywords = "Hemolytic uremic syndrome, Microangiopathic hemolytic anemia, Microcirculation, Platelet thrombi, Thrombocytopenia, Thrombotic microangiopathy, Thrombotic thrombocytopenic purpura",
author = "Roberto Pisoni and Giuseppe Remuzzi",
year = "2000",
month = "6",
doi = "10.1016/S0953-6205(00)00083-2",
language = "English",
volume = "11",
pages = "135--139",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",
number = "3",

}

TY - JOUR

T1 - Thrombotic microangiopathy

AU - Pisoni, Roberto

AU - Remuzzi, Giuseppe

PY - 2000/6

Y1 - 2000/6

N2 - The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while the term 'thrombotic thrombocytopenic purpura' (TTP) refers to adult cases of TMA with predominant neurological abnormalities. HUS and TTP show the same histological lesion characterized by widening of the subendothelial space and microvascular thrombosis and their different manifestations are secondary to the different distribution of the microvascular lesions. Available evidence orients towards endothelial injury as an important factor in the sequence of events leading to the microangiopathic process. Here we provide an overview of the pathophysiology, epidemiology, clinical manifestations, and management of TMA. (C) 2000 Elsevier Science B.V.

AB - The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while the term 'thrombotic thrombocytopenic purpura' (TTP) refers to adult cases of TMA with predominant neurological abnormalities. HUS and TTP show the same histological lesion characterized by widening of the subendothelial space and microvascular thrombosis and their different manifestations are secondary to the different distribution of the microvascular lesions. Available evidence orients towards endothelial injury as an important factor in the sequence of events leading to the microangiopathic process. Here we provide an overview of the pathophysiology, epidemiology, clinical manifestations, and management of TMA. (C) 2000 Elsevier Science B.V.

KW - Hemolytic uremic syndrome

KW - Microangiopathic hemolytic anemia

KW - Microcirculation

KW - Platelet thrombi

KW - Thrombocytopenia

KW - Thrombotic microangiopathy

KW - Thrombotic thrombocytopenic purpura

UR - http://www.scopus.com/inward/record.url?scp=0034111917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034111917&partnerID=8YFLogxK

U2 - 10.1016/S0953-6205(00)00083-2

DO - 10.1016/S0953-6205(00)00083-2

M3 - Article

VL - 11

SP - 135

EP - 139

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

IS - 3

ER -